Detalhe da pesquisa
1.
ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers.
Future Oncol
; 20(6): 307-315, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38410920
2.
Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial.
Am J Gastroenterol
; 117(6): 884-894, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35213393
3.
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
Lancet Oncol
; 22(10): 1468-1482, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34592180
4.
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111).
Int J Cancer
; 148(6): 1428-1437, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32930387
5.
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
BMC Cancer
; 21(1): 1206, 2021 Nov 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34772353
6.
Systemic Therapy for Metastatic Pancreatic Cancer.
Curr Treat Options Oncol
; 22(11): 106, 2021 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34665339
7.
Current status of immunotherapy in gastrointestinal malignancies.
Z Gastroenterol
; 58(6): 542-555, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32018315
8.
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
BMC Cancer
; 18(1): 1298, 2018 Dec 29.
Artigo
Inglês
| MEDLINE | ID: mdl-30594153
9.
Regorafenib.
Recent Results Cancer Res
; 211: 45-56, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30069758
10.
[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017]. / ASCO- und ESMO-Update 2017 Neuigkeiten vom 53. Meeting der American Society of Clinical Oncology/ASCO 2017 und European Society for Medical Oncology/ESMO-Congress 2017.
Z Gastroenterol
; 56(4): 384-397, 2018 04.
Artigo
Alemão
| MEDLINE | ID: mdl-29642252
11.
Surveillance after resection of pancreatic ductal adenocarcinoma with curative intent - a multicenter survey in Germany and review of the literature.
Z Gastroenterol
; 55(7): 657-666, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28437802
12.
S3-Leitlinie zum exokrinen Pankreaskarzinom Kurzversion 2.0 Dezember 2021, AWMF-Registernummer: 032/010OL.
Z Gastroenterol
; 60(6): 991-1037, 2022 06.
Artigo
Alemão
| MEDLINE | ID: mdl-35671996
13.
S3-Leitlinie zum exokrinen Pankreaskarzinom Langversion 2.0 Dezember 2021 AWMF-Registernummer: 032/010OL.
Z Gastroenterol
; 60(11): e812-e909, 2022 11.
Artigo
Alemão
| MEDLINE | ID: mdl-36368658
14.
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.
BMC Cancer
; 16: 21, 2016 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26772812
15.
Regorafenib.
Recent Results Cancer Res
; 201: 185-96, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24756792
16.
Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors.
Diagnostics (Basel)
; 14(2)2024 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38248074
17.
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
Oncol Res Treat
; 47(6): 251-261, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38565089
18.
Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial.
PLoS One
; 19(6): e0304324, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38875244
19.
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).
J Clin Oncol
; : JCO2301566, 2024 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38843469
20.
Gastroenteropancreatic Neuroendocrine Tumors-Current Status and Advances in Diagnostic Imaging.
Diagnostics (Basel)
; 13(17)2023 Aug 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37685279